Baud, Maxime O.
Rao, Vikram R.
Funding for this research was provided by:
University of Bern
Article History
Accepted: 23 September 2024
First Online: 29 October 2024
Declarations
:
: M.O. Baud holds shares with Epios SA, a medical device company based in Geneva, which is developing a subscalp EEG device. V.R. Rao is a former consultant for NeuroPace and a current investigator in the NIH-funded RNS System Lennox-Gastaut Syndrome (LGS) Feasibility Study (ClinicalTrials.gov Identifier: NCT05339126), but declares no targeted compensation for this study.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.